Trial intelligence / Profile preview

Phase II trial of Lutong capsule for preventive treatment of migraine

CTR20220907Phase 2Completed

Sponsor
Green Valley
Start
Sep 2022
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of Lutong Capsule in migraine, sponsored by Green Valley. Started Sep 2022; status: completed.

02

Drugs

Lutong Capsule
03

Conditions

migraine

Beyond the preview

Go deeper on CTR20220907.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20220907.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call